EUTM file information

015962673

TUMOR DEFENSE BREAKER

October 23, 2016

Trademark Summary

The trademark application TUMOR DEFENSE BREAKER was filed by HELIX IMMUNO-ONCOLOGY SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ, a corporation established under the laws of the Republic of Poland (the "Applicant"). Application refused.

The application was filed in Polish (English was selected as the second language).

Deletion of the representative of the trademark registration was recorded on February 12, 2017. Appointment and Replacement of representative of the trademark registration was recorded on March 13, 2017. Change of name and address of the trademark registration was recorded on April 11, 2017. Change of name and professional address of the trademark registration was recorded on June 20, 2017.

The Appeal with reference B R1543/2017-5 was Application rejected according to Article 7(1)(c) EUTMR with decision issued on September 28, 2017 by the EUIPO. The Refusal with reference B 015962673 was Rejected according to Article 7(1)(b) EUTMR with decision issued on May 15, 2017 by the EUIPO.

Goods And Services

  • The mark was filed in class 1 with Chemical compositions and materials for use in science and Chemical substances, chemical materials and chemical preparations, and natural elements..
  • The mark was filed in class 5 with following description of goods:
    1. Medical and veterinary preparations and articles
    2. Diagnostic preparations
    3. Pharmaceuticals and natural remedies
    4. Enzymes for medical purposes
    5. Enzyme preparations for medical purposes
    6. Biochemical preparations for medical use
    7. Chemical preparations for medical purposes
    8. Medicinal healthcare preparations.
  • The mark was filed in class 42 with following description of goods:
    1. Medical and pharmacological research services
    2. Genetic research
    3. Scientific research and analysis
    4. Research and development in the field of biotechnology
    5. Research laboratories.
  • The mark was filed in class 44 with Pharmaceutical services and Medical services..